36.4 USD
-1.24 (-3.29%)
36.4 USD
0 (0%)
Taking everything into account, ATRC scores 4 out of 10 in our fundamental rating. ATRC was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While ATRC has a great health rating, there are worries on its profitability. ATRC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- ATRC had negative earnings in the past year.
- In the past year ATRC had a positive cash flow from operations.
- ATRC had negative earnings in 4 of the past 5 years.
- In multiple years ATRC reported negative operating cash flow during the last 5 years.
1.2 Ratios
- The Return On Assets of ATRC (-4.60%) is better than 67.03% of its industry peers.
- ATRC has a Return On Equity of -6.13%. This is in the better half of the industry: ATRC outperforms 69.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.6% | ||
| ROE | -6.13% | ||
| ROIC | N/A |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ATRC has a better Gross Margin (74.87%) than 84.86% of its industry peers.
- In the last couple of years the Gross Margin of ATRC has remained more or less at the same level.
- ATRC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.87% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
2. Health
2.1 Basic Checks
- ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ATRC has more shares outstanding
- The number of shares outstanding for ATRC has been increased compared to 5 years ago.
- Compared to 1 year ago, ATRC has a worse debt to assets ratio.
2.2 Solvency
- ATRC has an Altman-Z score of 7.02. This indicates that ATRC is financially healthy and has little risk of bankruptcy at the moment.
- ATRC's Altman-Z score of 7.02 is amongst the best of the industry. ATRC outperforms 83.78% of its industry peers.
- ATRC has a debt to FCF ratio of 4.19. This is a neutral value as ATRC would need 4.19 years to pay back of all of its debts.
- ATRC has a Debt to FCF ratio of 4.19. This is amongst the best in the industry. ATRC outperforms 81.08% of its industry peers.
- ATRC has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.14, ATRC is doing good in the industry, outperforming 61.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.19 | ||
| Altman-Z | 7.02 |
ROIC/WACCN/A
WACC10%
2.3 Liquidity
- ATRC has a Current Ratio of 3.87. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
- ATRC's Current ratio of 3.87 is fine compared to the rest of the industry. ATRC outperforms 67.57% of its industry peers.
- A Quick Ratio of 2.85 indicates that ATRC has no problem at all paying its short term obligations.
- ATRC has a Quick ratio of 2.85. This is in the better half of the industry: ATRC outperforms 64.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.87 | ||
| Quick Ratio | 2.85 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 69.88% over the past year.
- Looking at the last year, ATRC shows a quite strong growth in Revenue. The Revenue has grown by 15.80% in the last year.
- The Revenue has been growing by 15.05% on average over the past years. This is quite good.
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
3.2 Future
- The Earnings Per Share is expected to grow by 23.01% on average over the next years. This is a very strong growth
- Based on estimates for the next years, ATRC will show a quite strong growth in Revenue. The Revenue will grow by 13.24% on average per year.
EPS Next Y46.71%
EPS Next 2Y33.2%
EPS Next 3Y31.6%
EPS Next 5Y23.01%
Revenue Next Year15.08%
Revenue Next 2Y13.66%
Revenue Next 3Y13.53%
Revenue Next 5Y13.24%
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ATRC. In the last year negative earnings were reported.
- Also next year ATRC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- ATRC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ATRC is cheaper than 69.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 111.31 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ATRC's earnings are expected to grow with 31.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.2%
EPS Next 3Y31.6%
5. Dividend
5.1 Amount
- ATRC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
36.4
-1.24 (-3.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners99.84%
Inst Owner Change0.05%
Ins Owners3.38%
Ins Owner Change-1.32%
Market Cap1.81B
Revenue(TTM)518.30M
Net Income(TTM)-29.20M
Analysts85.33
Price Target53.38 (46.65%)
Short Float %5.21%
Short Ratio4.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.89%
Min EPS beat(2)88.31%
Max EPS beat(2)91.46%
EPS beat(4)4
Avg EPS beat(4)71.41%
Min EPS beat(4)40.06%
Max EPS beat(4)91.46%
EPS beat(8)7
Avg EPS beat(8)36.37%
EPS beat(12)11
Avg EPS beat(12)39.56%
EPS beat(16)11
Avg EPS beat(16)28.77%
Revenue beat(2)2
Avg Revenue beat(2)1.41%
Min Revenue beat(2)0.29%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)2.54%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)6
Avg Revenue beat(12)0.47%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)1.29%
PT rev (3m)2.61%
EPS NQ rev (1m)14.11%
EPS NQ rev (3m)4.6%
EPS NY rev (1m)2.15%
EPS NY rev (3m)24.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.49 | ||
| P/FCF | 111.31 | ||
| P/OCF | 42.15 | ||
| P/B | 3.8 | ||
| P/tB | 9.45 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.33
FCFY0.9%
OCF(TTM)0.86
OCFY2.37%
SpS10.42
BVpS9.58
TBVpS3.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.6% | ||
| ROE | -6.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.87% | ||
| FCFM | 3.14% |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score7
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 133.13% | ||
| Cap/Sales | 5.15% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.87 | ||
| Quick Ratio | 2.85 | ||
| Altman-Z | 7.02 |
F-Score7
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
EPS Next Y46.71%
EPS Next 2Y33.2%
EPS Next 3Y31.6%
EPS Next 5Y23.01%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
Revenue Next Year15.08%
Revenue Next 2Y13.66%
Revenue Next 3Y13.53%
Revenue Next 5Y13.24%
EBIT growth 1Y21.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.64%
EBIT Next 3Y64.51%
EBIT Next 5Y43.19%
FCF growth 1Y137.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8487.4%
OCF growth 3YN/A
OCF growth 5YN/A
ATRICURE INC / ATRC FAQ
What is the fundamental rating for ATRC stock?
ChartMill assigns a fundamental rating of 4 / 10 to ATRC.
What is the valuation status for ATRC stock?
ChartMill assigns a valuation rating of 2 / 10 to ATRICURE INC (ATRC). This can be considered as Overvalued.
What is the profitability of ATRC stock?
ATRICURE INC (ATRC) has a profitability rating of 3 / 10.
What is the financial health of ATRICURE INC (ATRC) stock?
The financial health rating of ATRICURE INC (ATRC) is 7 / 10.